Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Aldosterone synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬Aldosterone synthesis and secretion
| Suvecaltamide | 006 1件: 6 💬1. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Aldosterone synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬Aldosterone synthesis and secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬2. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Aldosterone synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬Aldosterone synthesis and secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬2. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Aldosterone synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬Aldosterone synthesis and secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬2. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Aldosterone synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬Aldosterone synthesis and secretion
| Zonisamide | 006 1件: 6 💬5. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬Calcium signaling pathway
| Suvecaltamide | 006 1件: 6 💬6. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬Calcium signaling pathway
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬7. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬Calcium signaling pathway
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬7. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬Calcium signaling pathway
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬7. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬Calcium signaling pathway
| Zonisamide | 006 1件: 6 💬10. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Circadian entrainment 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬Circadian entrainment
| Suvecaltamide | 006 1件: 6 💬11. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Circadian entrainment 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬Circadian entrainment
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬12. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Circadian entrainment 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬Circadian entrainment
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬12. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Circadian entrainment 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬Circadian entrainment
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬12. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Circadian entrainment 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬Circadian entrainment
| Zonisamide | 006 1件: 6 💬15. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Cortisol synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬Cortisol synthesis and secretion
| Suvecaltamide | 006 1件: 6 💬16. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Cortisol synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬Cortisol synthesis and secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬17. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Cortisol synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬Cortisol synthesis and secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬17. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Cortisol synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬Cortisol synthesis and secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬17. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Cortisol synthesis and secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬Cortisol synthesis and secretion
| Zonisamide | 006 1件: 6 💬20. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Cushing syndrome 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬Cushing syndrome
| Suvecaltamide | 006 1件: 6 💬21. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Cushing syndrome 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬Cushing syndrome
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬22. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Cushing syndrome 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬Cushing syndrome
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬22. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Cushing syndrome 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬Cushing syndrome
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬22. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Cushing syndrome 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬Cushing syndrome
| Zonisamide | 006 1件: 6 💬25. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | GnRH secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬GnRH secretion
| Suvecaltamide | 006 1件: 6 💬26. GnRH secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | GnRH secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬GnRH secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬27. GnRH secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | GnRH secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬GnRH secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬27. GnRH secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | GnRH secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬GnRH secretion
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬27. GnRH secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | GnRH secretion 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬GnRH secretion
| Zonisamide | 006 1件: 6 💬30. GnRH secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬MAPK signaling pathway
| Suvecaltamide | 006 1件: 6 💬31. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬MAPK signaling pathway
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬32. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬MAPK signaling pathway
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬32. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬MAPK signaling pathway
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬32. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬MAPK signaling pathway
| Zonisamide | 006 1件: 6 💬35. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Type II diabetes mellitus 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Suvecaltamide Suvecaltamide 💬Type II diabetes mellitus
| Suvecaltamide | 006 1件: 6 💬36. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Type II diabetes mellitus 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Divalproex sodium Divalproex sodium 💬Type II diabetes mellitus
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬37. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Type II diabetes mellitus 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproic acid Valproic acid 💬Type II diabetes mellitus
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬37. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Type II diabetes mellitus 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Valproate sodium Valproate sodium 💬Type II diabetes mellitus
| Valproic acid | 002 13件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬37. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Type II diabetes mellitus 💬 1 gene, 3 drugs (DrugBank) and 13 diseases |
CACNA1G 1件: CACNA1G 💬Aldosterone synthesis and secretion
|
Zonisamide Zonisamide 💬Type II diabetes mellitus
| Zonisamide | 006 1件: 6 💬40. Type II diabetes mellitus
|
Aldosterone synthesis and secretion
1 gene, 3 drugs (DrugBank) and 13 diseases
Calcium signaling pathway
1 gene, 3 drugs (DrugBank) and 13 diseases
Circadian entrainment
1 gene, 3 drugs (DrugBank) and 13 diseases
Cortisol synthesis and secretion
1 gene, 3 drugs (DrugBank) and 13 diseases
Cushing syndrome
1 gene, 3 drugs (DrugBank) and 13 diseases
GnRH secretion
1 gene, 3 drugs (DrugBank) and 13 diseases
MAPK signaling pathway
1 gene, 3 drugs (DrugBank) and 13 diseases
Type II diabetes mellitus
1 gene, 3 drugs (DrugBank) and 13 diseases